Treatment of COVID-19 in pregnancy
Read our monograph on COVID-19 treatments in pregnancy for the most up-to-date information on COVID-19 treatment.
COVID-19 Antivirals Pregnancy Registry
We are gathering information about the use of COVID-19 antivirals in pregnancy (UKHSA/MHRA collaboration). Please report into our registry.
COVID-19 vaccination in pregnancy
Read our monograph on the use of non-live vaccines (including COVID-19) during pregnancy.
Use of therapeutic amfetamines in pregnancy
Due to the considerable number of enquiries we have received about treating ADHD in pregnancy with lisdexamfetamine, we have published a summary of the available safety evidence for therapeutic amfetamines.
Use of methylphenidate in pregnancy
Our latest publication – We applied a meta-analysis approach to summarise the published evidence on cardiac malformation risk after first trimester methylphenidate use. Read the paper here. Also see our recently updated systematic evidence review on the use of methylphenidate in pregnancy.
High-dose folic acid in WWE and cancer risk
In response to the results of a large multi-national study investigating cancer risks in the offspring of women with epilepsy who used high-dose folic acid in pregnancy we have prepared a position statement providing our interpretation of the evidence. High-dose folic acid use in women with epilepsy in pregnancy and childhood cancer risk – UKTIS.
Latest papers from the field of teratology
UKTIS on TwitterTweets by medsinpregnancy
Who are UKTIS?
UKTIS is commissioned by the UK Health Security Agency (UKHSA) and hosted by The Newcastle upon Tyne Hospitals NHS Foundation Trust to perform national surveillance of known and emerging human teratogens.
Information collected by UKTIS is recognised by the Caldicott Advisory Panel of UKHSA.